Trial Outcomes & Findings for Accommodation Measurements After Bilateral Implantation of an Aspheric Accommodating Lens and Monofocal Aspheric Lenses (NCT NCT01241279)

NCT ID: NCT01241279

Last Updated: 2014-11-26

Results Overview

The measurement of optical change in the power of the eye when viewing from far to near. Accommodation decreases as age increases resulting in an inability to focus on near objects.

Recruitment status

TERMINATED

Study phase

PHASE4

Target enrollment

6 participants

Primary outcome timeframe

Visit 4 (postoperative day 120-180)

Results posted on

2014-11-26

Participant Flow

A total of 6 subjects (11 eyes) were enrolled at one investigational site in the US. First participant enrolled 10/26/2010; last participant visit 12/01/2011.

Due to the small sample size, NO STATISTICAL OR CLINICALLY MEANINGFUL CONCLUSIONS RELATED TO THE STUDY ENDPOINTS CAN BE MADE.

Participant milestones

Participant milestones
Measure
Crystalens AO
A silicone multi-piece accommodating intraocular lens
SoftPort LI61AO
A silicone multi-piece foldable aspheric intraocular lens
Overall Study
STARTED
4
2
Overall Study
COMPLETED
4
1
Overall Study
NOT COMPLETED
0
1

Reasons for withdrawal

Reasons for withdrawal
Measure
Crystalens AO
A silicone multi-piece accommodating intraocular lens
SoftPort LI61AO
A silicone multi-piece foldable aspheric intraocular lens
Overall Study
Lost to Follow-up
0
1

Baseline Characteristics

Accommodation Measurements After Bilateral Implantation of an Aspheric Accommodating Lens and Monofocal Aspheric Lenses

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Crystalens AO
n=4 Participants
A silicone multi-piece accommodating intraocular lens
SoftPort LI61AO
n=2 Participants
A silicone multi-piece foldable aspheric intraocular lens
Total
n=6 Participants
Total of all reporting groups
Age, Customized
Age 54 to 70 years
4 participants
n=5 Participants
2 participants
n=7 Participants
6 participants
n=5 Participants
Sex: Female, Male
Female
2 Participants
n=5 Participants
1 Participants
n=7 Participants
3 Participants
n=5 Participants
Sex: Female, Male
Male
2 Participants
n=5 Participants
1 Participants
n=7 Participants
3 Participants
n=5 Participants

PRIMARY outcome

Timeframe: Visit 4 (postoperative day 120-180)

Population: DUE TO THE SMALL SAMPLE SIZE, NO STATISTICAL OR CLINICALLY MEANINGFUL CONCLUSIONS RELATED TO THE STUDY ENDPOINTS CAN BE MADE.

The measurement of optical change in the power of the eye when viewing from far to near. Accommodation decreases as age increases resulting in an inability to focus on near objects.

Outcome measures

Outcome data not reported

SECONDARY outcome

Timeframe: All visits through visit 4 (day 160-180)

Population: DUE TO THE SMALL SAMPLE SIZE, NO STATISTICAL OR CLINICALLY MEANINGFUL CONCLUSIONS RELATED TO THE STUDY ENDPOINTS CAN BE MADE.

Number of correct letters on an early treatment diabetic retinopathy study (ETDRS) chart to measure distance visual acuity and the smallest readable print size on an Minnesota Low-Vision Reading (MNREAD) acuity chart for intermediate and near visual acuity (VA). Visual acuity measured in LogMAR.

Outcome measures

Outcome data not reported

Adverse Events

Crystalens AO

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

SoftPort LI61AO

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Johnson Varughese

Valeant Pharmaceuticals/Bausch & Lomb

Phone: 908-927-1162

Results disclosure agreements

  • Principal investigator is a sponsor employee Study data generated as a result of this study will be regarded as confidential, until appropriate analysis and review by the Sponsor or its designee and the Investigator(s) are completed. The results of the study may be published or presented by the Investigator(s) after the review by, and in consultation and agreement with the Sponsor, and such that confidential or proprietary information is not disclosed.
  • Publication restrictions are in place

Restriction type: OTHER